Thiotepa Fresenius Kabi 15 mg powder for concentrate for solution for infusion

Licence status
Authorised: 05/05/2023
Active substances
Thiotepa
Dosage Form
Powder for concentrate for solution for infusion
Licence number
PA2059/079/001
Licence holder
Fresenius Kabi Deutschland GmbH

Product documents

Licence information

ATC code
L01AC01 thiotepa
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2)
Marketing availability
Not marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
05/05/2023